These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21569225)

  • 1. Regulated competition in health care: switching and barriers to switching in the Dutch health insurance system.
    Reitsma-van Rooijen M; de Jong JD; Rijken M
    BMC Health Serv Res; 2011 May; 11():95. PubMed ID: 21569225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dutch health insurance reform: switching between insurers, a comparison between the general population and the chronically ill and disabled.
    de Jong JD; van den Brink-Muinen A; Groenewegen PP
    BMC Health Serv Res; 2008 Mar; 8():58. PubMed ID: 18366678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the chronically ill population in the Netherlands switch their health insurer as often as the general population? Empirical evidence from a nationwide survey study.
    van der Schors W; Brabers AEM; De Jong JD
    BMC Health Serv Res; 2020 May; 20(1):376. PubMed ID: 32370798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching health insurers: the role of price, quality and consumer information search.
    Boonen LH; Laske-Aldershof T; Schut FT
    Eur J Health Econ; 2016 Apr; 17(3):339-53. PubMed ID: 25820635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why do people not switch insurer in a market-based health insurance market? Empirical evidence from the Netherlands.
    van der Schors W; Brabers AEM; de Jong JD
    Eur J Public Health; 2020 Aug; 30(4):633-638. PubMed ID: 32236545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching benefits and costs in competitive health insurance markets: A conceptual framework and empirical evidence from the Netherlands.
    Duijmelinck DM; Mosca I; van de Ven WP
    Health Policy; 2015 May; 119(5):664-71. PubMed ID: 25530069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intention to switch health insurer and actual switching behaviour: are there differences between groups of people?
    Hendriks M; de Jong JD; van den Brink-Muinen A; Groenewegen PP
    Health Expect; 2010 Jun; 13(2):195-207. PubMed ID: 19906212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching benefits and costs in the Irish health insurance market: an analysis of consumer surveys.
    Keegan C; Teljeur C; Turner B; Thomas S
    Int J Health Econ Manag; 2019 Mar; 19(1):15-32. PubMed ID: 29748937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disability in two health care systems: access, quality, satisfaction, and physician contacts among working-age Canadians and Americans with disabilities.
    Gulley SP; Altman BM
    Disabil Health J; 2008 Oct; 1(4):196-208. PubMed ID: 21122730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching rates in health insurance markets decrease with age: empirical evidence and policy implications from the Netherlands.
    Duijmelinck DM; van de Ven WP
    Health Econ Policy Law; 2016 Apr; 11(2):141-59. PubMed ID: 26173559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does supplementary health insurance play a role in the switching behaviour of citizens in the Netherlands?
    Holst L; Brabers A; de Jong J
    J Mark Access Health Policy; 2022; 10(1):2015863. PubMed ID: 34925712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What health plans do people prefer? The trade-off between premium and provider choice.
    Determann D; Lambooij MS; de Bekker-Grob EW; Hayen AP; Varkevisser M; Schut FT; Wit GA
    Soc Sci Med; 2016 Sep; 165():10-18. PubMed ID: 27485728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplementary insurance as a switching cost for basic health insurance: Empirical results from the Netherlands.
    Willemse-Duijmelinck DMID; van de Ven WPMM; Mosca I
    Health Policy; 2017 Oct; 121(10):1085-1092. PubMed ID: 28855064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consumer price sensitivity in Dutch health insurance.
    van Dijk M; Pomp M; Douven R; Laske-Aldershof T; Schut E; de Boer W; de Boo A
    Int J Health Care Finance Econ; 2008 Dec; 8(4):225-44. PubMed ID: 18709549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching insurer in the Irish voluntary health insurance market: determinants, incentives, and risk equalization.
    Keegan C; Teljeur C; Turner B; Thomas S
    Eur J Health Econ; 2016 Sep; 17(7):823-31. PubMed ID: 26359243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and reasons for delaying and foregoing necessary care by the presence and type of disability among working-age adults.
    Reichard A; Stransky M; Phillips K; McClain M; Drum C
    Disabil Health J; 2017 Jan; 10(1):39-47. PubMed ID: 27771217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching health insurance plans: results from a health survey.
    Lako CJ; Rosenau P; Daw C
    Health Care Anal; 2011 Dec; 19(4):312-28. PubMed ID: 20640891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managed competition and consumer price sensitivity in social health insurance.
    Schut FT; Hassink WH
    J Health Econ; 2002 Nov; 21(6):1009-29. PubMed ID: 12475123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insurance Transitions and Changes in Physician and Emergency Department Utilization: An Observational Study.
    Barnett ML; Song Z; Rose S; Bitton A; Chernew ME; Landon BE
    J Gen Intern Med; 2017 Oct; 32(10):1146-1155. PubMed ID: 28523475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching gains and health plan price elasticities: 20 years of managed competition reforms in The Netherlands.
    Douven R; Katona K; T Schut F; Shestalova V
    Eur J Health Econ; 2017 Nov; 18(8):1047-1064. PubMed ID: 28243775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.